Breakthrough Heart Support Technologies

Abiomed's portfolio of heart support and recovery products and services offer healthcare professionals an array of choices across a broad clinical spectrum, from the catheterization lab to the surgical suite, together with interventional cardiologists and surgeons. 

Impella® Platform

Percutaneous, Catheter Based

Impella.2.5

Impella 2.5

In March 2015, the Impella 2.5 received FDA approval for elective and urgent high risk PCI procedures.

impella-cp

Impella CP ®

In September 2012, the Impella CP received FDA 510(K) clearance for partial circulatory support for periods up to 6 hours.

impella-rp

Impella RPTM

In January 2015, the Impella RP received FDA HDE approval as the first percutaneous single access heart pump designed for right heart support.

Impella.5.0

Impella 5.0

In April 2009, the Impella 5.0 received FDA 510(K) clearance for circulatory support for periods up to 6 hours.

Impella.LD

Impella LD

In April 2009, the Impella LD received FDA 510(k) clearance for circulatory support for periods up to 6 hours.

impella-controller

Automated Impella Controller

In July 2010, the Impella® Controller received FDA 510(k) clearance for intended use by trained healthcare professionals in healthcare facilities and medical transport (ie, ambulance, helicopter, or fixed-wing aircraft) environments.

« back to top